Viridian Therapeutics (0K1R.L) Stock Price
$19.09 4.7%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
6 -
Technical
6
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Viridian Therapeutics, AI stock picks, stock alerts and much more.
0K1R.L AI Stock Analysis
AI stock analysis for 0K1R.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Viridian Therapeutics (0K1R.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Viridian Therapeutics (0K1R.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Viridian Therapeutics (0K1R.L), currently trading at $19.09, will... Sign up to access price prediction.
About 0K1R.L
-
Viridian Therapeutics, Inc.
-
Symbol
0K1R.L
-
Market
LSE
-
Industry
Biotechnology
-
Market Cap
1.6B
Similar Stocks
 |
Codexis 0I0X.L |
$2.41 2.4% |
5 |
 |
Oxford Nanopore Technologies plc ONT.L |
£164.1 3.5% |
6 |
 |
Sareum Holdings SAR.L |
£24 0.00% |
6 |
 |
Avacta Group Plc AVCT.L |
£55 0.00% |
3 |
 |
ImmuPharma IMM.L |
£14.25 31.3% |
6 |
News
0K1R.L Alternative Data
Web Traffic
Viridian Therapeutics receives an estimated 5843 monthly visitors to viridiantherapeutics.com, which is down by -43.9% over the last month.
-
Web Traffic
5843
-
Change from Previous Month
43.9%
-
3 Month Change
6.9%
-
YoY Change
6.9%
Twitter Followers
Viridian Therapeutics has 819 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.1% over the last month.
-
Twitter Followers
819
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0.1%
-
YoY Change
0.1%
Instagram Followers
Viridian Therapeutics has 644 Instagram Followers on its main Instagram account, up by 0.2% over the last month.
-
Instagram Followers
644
-
Daily Change
0%
-
1 Month Change
0.2%
-
3 Month Change
0.6%
-
YoY Change
0.6%
Job Postings
Viridian Therapeutics currenly has an estimated 23 open job postings, up by 64.3% over the last month.
-
Job Postings
23
-
Daily Change
0%
-
1 Month Change
64.3%
-
3 Month Change
64.3%
-
YoY Change
64.3%
Reddit Mentions
Viridian Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
16,562 are following Viridian Therapeutics on LinkedIn, up by 6.1% over the last month.
-
LinkedIn Followers
16562
-
Daily Change
6.1%
-
1 Month Change
6.1%
-
3 Month Change
14.7%
-
YoY Change
14.7%
Business Outlook
According to employee reviews, the business outlook among employees at Viridian Therapeutics is 57 out of 100 (neutral).
-
Business Outlook
57
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Viridian Therapeutics has 224 employees, up by 3.7% over the last month.
-
LinkedIn Employees
224
-
Daily Change
3.7%
-
1 Month Change
3.7%
-
3 Month Change
10.3%
-
YoY Change
10.3%
News Mentions
Viridian Therapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0K1R.L Financials
0K1R.L Key Metrics
-
Total Revenue
$72K
-
Net Income
-$86.9M
-
Earnings per Share
-$0.87
-
Free cash flow
-$92.7M
-
EBITDA
-$86.2M
-
EBITDA Ratio
-1197.35
-
Total Assets
$661M
0K1R.L 2-year Revenue & Income
0K1R.L 2-year Free Cash Flow
0K1R.L Technicals
0K1R.L SMA
0K1R.L RSI
FAQ
What's the current price of Viridian Therapeutics (0K1R.L) Stock?
The price of an Viridian Therapeutics (0K1R.L) share is $19.09.
What's the market cap of Viridian Therapeutics?
The current market cap of Viridian Therapeutics is 1.6B.
What are some stocks similar to Viridian Therapeutics (0K1R.L) that investors often compare it to?
Viridian Therapeutics (0K1R.L) is often compared to similar stocks such as Codexis, Oxford Nanopore Technologies plc, Sareum Holdings, Avacta Group Plc and ImmuPharma.
What is the forecast for Viridian Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Viridian Therapeutics' stock price to be around $19.38 in 2026. Starting from the current price of $19.09, this represents a 1.6% change in price, indicating a neutral outlook for the stock.
How to buy Viridian Therapeutics (0K1R.L) Stock?
Viridian Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Viridian Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.